Login / Signup

Treatment of severe, refractory pyoderma gangrenosum with infliximab, adalimumab and intravenous immunoglobulin.

Zachary HolmesJacqueline K NguyenAshling CourtneyDale JobsonRobert Kelly
Published in: The Australasian journal of dermatology (2023)
Keyphrases
  • rheumatoid arthritis
  • ulcerative colitis
  • high dose
  • early onset
  • systemic lupus erythematosus
  • combination therapy